India’s Cadila to produce up to 3 crore COVID-19 vaccine doses a month –...
India’s Cadila Healthcare is aiming to triple monthly production of a COVID-19 vaccine candidate to as many as 3 crore doses, its managing director...
India’s Panacea Biotec begins producing Russia’s Sputnik V vaccine – RDIF
Indian biotech firm Panacea Biotec Ltd, on Monday, began production of Russia's Sputnik V vaccine against COVID-19, said the Russian Direct Investment Fund (RDIF), which markets the...
Temple in Coimbatore consecrates ‘Corona Devi’ idol to protect people from Covid-19 pandemic
Kamatchipuri Adhinam, a temple in Coimbatore, has consecrated a 'Corona Devi' idol to protect people from the deadly Covid-19 virus.
The manager and priest of...
Chipko Movement founder Sundarlal Bahuguna succumbs to COVID-19
Sunderlal Bahuguna spent his lifetime teaching and persuading the villagers to oppose deforestation and the devastation of the Himalayan ranges. He is known for...
Plasma therapy dropped from ICMR COVID-19 treatment protocols
The use of convalescent plasma has been dropped from the recommended treatment protocols for COVID-19, according to the latest guidelines released by the Indian...
First batch of DRDO’s anti-COVID drug 2DG released
The first batch of anti-COVID oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister...
Dehradun’s Abhimanyu Easwaran selected in Indian Cricket Team for England tour
Dehradun's ace cricket player Abhimanyu Easwaran has been selected in the Indian Cricket Team led by captain Virat Kohli. He has been selected in...
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to...
The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age...
Govt Panel recommends 12-16 week gap between Covishield doses
The National Technical Advisory Group on Immunisation (NTAGI), on Thursday, recommended an increase in the gap between two doses of Serum Institute of India's...
DRDO’s anti-COVID drug is safe, will help patients recover faster: Dr. Sudhir Chandna
Dr. Sudhir Chandna, a scientist at the Institute of Nuclear Medicine and Allied Sciences (INMAS), informed on Sunday that the recently approved anti-COVID drug...
